CLINICAL_TRIALS
trial_result
· 2020-09-24
Clinical Trial Update: A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain [Phase 3]
Summary
Phase 3 open-label study assessing safety of TRV130 in patients with acute pain has completed and results were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Trevena Inc. | Conditions: Acute Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-09-24